What is the role of adding aspirin in PIK3CA mutated patients?
What is the role of adding aspirin in PIK3CA mutated patients?
Assoc. Prof. Gerald Prager
The Clinical Question: What is the role of adding aspirin in PIK3CA mutated patients? has been discussed by Assoc. Prof. Gerald Prager and Prof. David Tougeron.Assoc. Prof. Gerald Prager
Medical Oncologist
Medical University of Vienna
Austria
Assoc. Prof. Gerald Prager has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:
| 5 min | 2017
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
Was valuable to me:
1/4
Has improved my knowledge of this topic:
2/4
Is likely to change my clinical practice:
3/4
Was balanced and unbiased:
4/4
GI CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer.